Corticotropin releasing factor receptor antagonists for major depressive disorder
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Major depressive disorder is a serious and common psychiatric illness, and many of the depressive patients benefit from pharmacological treatment. Available antidepressants produce remission in only about 30 -- 40% of the patients. Therefore, new concepts are being explored for the development of innovative antidepressants with higher efficacy. AREAS COVERED: The use of corticotropin releasing factor type 1 (CRF1) receptor antagonists for depression is supported by abundant evidence of target validation, the availability of in vitro and in vivo assays and specific small ligands. Some of these compounds have advanced to clinical studies, with discouraging results so far in depression. This review covers the development of CRF1 receptor antagonists at different stages of the development pipeline of the pharmaceutical industry and its bottlenecks. Most of the available CRF1 receptor antagonists known so far share a common chemical scaffold. We present possible strategies to overcome obstacles in the discovery and development process at the levels of library screenings and clinical studies to find more diverse compounds. EXPERT OPINION: CRF1 receptor antagonists are expected to be beneficial only for those patients with CRF overexpression and the need for tests to identify these individuals is discussed. New technical developments and diagnostic tools might eventually lead to a more successful treatment of major depression with CRF1 receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“5% of the patients, as has been reported for a study with a serotonin reuptake inhibitor [5].”
BackgroundEpidemiology of women and depression
Kessler, R. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00426-3 · Cited by 2,006 · cited 1×
“Major depression is a frequent affective disorder with lifetime prevalence up to 15% in the industrialized world [2,3].”
BackgroundThe link between childhood trauma and depression: insights from HPA axis studies in humans
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.008 · Cited by 1,704
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 4×
“4 The need for patient stratification for CRF1 receptor antagonist treatment A careful analysis of the data on CRF levels in the cerebrospinal fluid of depressive patients in comparison to normal subjects shows that among the depressive population some individuals have increased amounts while some others are within th…”
BackgroundInfluentialThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“An impaired regulation of the HPA axis is the most robust laboratory finding in patients with major depression [13,26-28].”
BackgroundJACOBI, F., WITTCHEN, H.-U., HÖLTING, C., HÖFLER, M., PFISTER, H., MÜLLER, N., & LIEB, R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001399 · Cited by 1,097 · cited 1×
“Major depression is a frequent affective disorder with lifetime prevalence up to 15% in the industrialized world [2,3].”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 4×
“There is also a strong correlation between FKBP5 mRNA expression in peripheral lymphocytes and serum cortisol levels in individuals carrying the genotypes associated with fast response to antidepressants than the other genotypes, indicating an altered GR/FKBP5 feedback mechanism associated with these genotypes [10,122…”
BackgroundSelf-citationLewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · cited 4×
“They only share ~ 30 -- 40% homology with r/hCRF and urocortin, but the homology between mouse and human is 76% for SRP/ UCN2 and 90% for SCP/UCN3.”
BackgroundInfluentialTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919 · cited 2×
“The CRF1 receptor-deficient mice, on the other hand, exhibit low plasma ACTH and corticosterone levels, reduced stress response and very low anxiety-like behavior [75,76].”
BackgroundResultSelf-citationSmith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887 · cited 4×
“They only share ~ 30 -- 40% homology with r/hCRF and urocortin, but the homology between mouse and human is 76% for SRP/ UCN2 and 90% for SCP/UCN3.”
BackgroundInfluentialRaadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
Self-citationChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473 · cited 11×
“Many studies in animal models corroborated the view that increased CRF accounts not only for the endocrine stress response, but also acts as a key regulator of the behavioral adaptation to stress [37,38].”
BackgroundMethodSelf-citationFrancis, D. D., Caldji, C., Champagne, F., Plotsky, P. M., & Meaney, M. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00237-1 · Cited by 380 · cited 1×
“There is, however, abundant evidence that genetic vulnerability in combination with external stressors affects various biochemical processes that may trigger the manifestation of depressive symptoms [11-13].”
BackgroundCorticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
Heinrichs, S. C., & Koob, G. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052092 · Cited by 353 · cited 1×
“Besides starting the activation of the HPA axis at the PVN, CRF is widely expressed throughout the CNS, localized in the limbic system and the prefrontal cortex, where it regulates neuronal function integrating complex neuroendocrine and autonomic responses to stress with numerous behaviors, such as anxiety, arousal,…”
BackgroundIsing, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 2×
“This concept is supported by a large number of studies showing that the normalization of initially disturbed HPA axis activity precedes the normalization of depressive symptoms after antidepressant treatment [41].”
BackgroundSelf-citationVermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020354 · Cited by 285 · cited 1×
“There is also a strong correlation between FKBP5 mRNA expression in peripheral lymphocytes and serum cortisol levels in individuals carrying the genotypes associated with fast response to antidepressants than the other genotypes, indicating an altered GR/FKBP5 feedback mechanism associated with these genotypes [10,122…”
BackgroundLekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284 · cited 1×
“Polymorphisms within the locus of FKBP5, encoding the GR-regulating co-chaperone of hsp90, are associated with the response to antidepressant treatment [10,118-120].”
BackgroundHolsboer, F., von Bardeleben, U., & Steiger, A. (2008) · Neuroendocrinology · doi:10.1159/000124986 · Cited by 255 · cited 1×
“These results are in line with the effects on sleep EEG produced by the overexpression of CRF in mice and the intravenous injection of CRF in men [105,106].”
ResultSelf-citationBinneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · cited 8×
“The CRF1a splice variant is primarily found in the CNS, whereas the CRF1b receptor subtype is expressed in both the brain and the periphery.”
BackgroundInfluentialGenetic Variants in FKBP5 Affecting Response to Antidepressant Drug Treatment
Kirchheiner, J., Lorch, R., Lebedeva, E., Seeringer, A., Roots, I., Sasse, J., & Brockmöller, J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.841 · Cited by 104 · cited 1×
“Polymorphisms within the locus of FKBP5, encoding the GR-regulating co-chaperone of hsp90, are associated with the response to antidepressant treatment [10,118-120].”
BackgroundSchmidt, M. V., Trümbach, D., Weber, P., Wagner, K., Scharf, S. H., Liebl, C., Datson, N., Namendorf, C., Gerlach, T., Kühne, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4668-10.2010 · Cited by 91 · cited 1×
“Therefore, stress is considered a factor that contributes to triggering depressive episodes, and the components of the response to stress might hold the key to understanding and treating some of the patients with major depression, in particular those who are genetically more vulnerable to stress [17].”
BackgroundSelf-citationFabio, R. D., St-Denis, Y., Sabbatini, F. M., Andreotti, D., Arban, R., Bernasconi, G., Braggio, S., Blaney, F. E., Capelli, A. M., Castiglioni, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800744m · Cited by 34 · cited 1×
“gov Identifier: NCT00397722), but no results have been published so far [110].”
Background
Cited by
Wu, G., Feder, A., Cohen, H., Kim, J. J., Calderon, S., Charney, D. S., & Mathé, A. A. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00010 · Cited by 726
Key role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
The Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
Metadata
- Authors
- Paez-Pereda, M., Hausch, F., & Holsboer, F.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2011-03-14
- Volume
- 20
- Issue
- 4
- Pages
- 519-535
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2059784555
- Cited by
- 58
- References
- 27
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.